NASDAQ

Inovio Pharmaceuticals, Inc. (INO)

♥ 512 Thanks from members

Live price chart, market sentiment, and community perspectives for Inovio Pharmaceuticals, Inc. (NASDAQ: INO).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Dr. David WeinerLeadership: Jackie Shea (President and CEO)Leadership: Michael Sumner (Chief Medical Officer)Holder: The Vanguard GroupHolder: BlackRock Inc.Holder: State Street CorporationCELLECTRA delivery deviceHPV immunotherapy candidatesDNA vaccine pipeline#INO#Inovio Pharmaceuticals#DNA medicines#biotech stock#immunotherapy